Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alessandra Virga
Observed name:
A. Virga
Institutions:
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori,
Princess Máxima Center,
Centro di Riferimento Oncologico
Observed institutions:
Novartis (Switzerland),
University of Debrecen,
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori,
Princess Máxima Center,
Centro di Riferimento Oncologico
ORCID:
0000-0001-9427-3875
Observed ORCID:
0000-0001-9427-3875
OpenAlex ID:
A5057344649
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer
2022
·
Caterina Gianni
, Michela Palleschi
, et al.
·
International Journal of Molecular Sciences
·
39
PDF
Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives
2022
·
Marianna Sirico
, Alessandra Virga
, et al.
·
Critical Reviews in Oncology/Hematology
·
38
Dynamic Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer
2023
·
Milena Urbini
, Giorgia Marisi
, et al.
·
JCO Precision Oncology
·
25
PDF
Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma
2021
·
Vincenza Conteduca
, Emanuela Scarpi
, et al.
·
Frontiers in Oncology
·
17
PDF
Immunosenescence in Testicular Cancer Survivors: Potential Implications of Cancer Therapies and Psychological Distress
2021
·
Silvia De Padova
, Milena Urbini
, et al.
·
Frontiers in Oncology
·
17
PDF
Primary Mediastinal and Testicular Germ Cell Tumors in Adolescents and Adults: A Comparison of Genomic Alterations and Clinical Implications
2021
·
Milena Urbini
, Giuseppe Schepisi
, et al.
·
Cancers
·
16
PDF
Moving beyond PARP Inhibition: Current State and Future Perspectives in Breast Cancer
2021
·
Michela Palleschi
, Gianluca Tedaldi
, et al.
·
International Journal of Molecular Sciences
·
14
PDF
A Novel AKT1, ERBB2, ESR1, KRAS, PIK3CA, and TP53 NGS Assay: A Non-Invasive Tool to Monitor Resistance Mechanisms to Hormonal Therapy and CDK4/6 Inhibitors
2024
·
Alessandra Virga
, Caterina Gianni
, et al.
·
Biomedicines
·
10
PDF
Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients
2022
·
Giorgia Gurioli
, Gianluca Tedaldi
, et al.
·
International Journal of Molecular Sciences
·
9
PDF
Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer
2025
·
Vincenza Conteduca
, Emanuela Scarpi
, et al.
·
The Oncologist
·
8
PDF
Impact of Circulating Tumor DNA and Copy-Number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated With Salvage High-Dose Chemotherapy
2026
·
Milena Urbini
, Thomas F. Eleveld
, et al.
·
Journal of Clinical Oncology
·
7
Genomic and Transcriptomic Profiles in Smokers and Never-Smokers Lung Squamous Cell Carcinoma Patients
2025
·
Matteo Canale
, Alessandra Virga
, et al.
·
Lung Cancer Targets and Therapy
·
5
PDF
Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants
2025
·
Michela Palleschi
, Alessandra Virga
, et al.
·
The Oncologist
·
5
PDF
LBA71 Open-label, multicentre randomised trial of Radium223-docetaxel versus docetaxel-Radium223 sequence in metastatic castration resistant prostate cancer (mCRPC) with prospective biomarker evaluation (RAPSON study)
2024
·
V. Conteduca
, N. Brighi
, et al.
·
Annals of Oncology
·
5
PDF
167P Exploring the role of rare germline variants in non-coding regions of cancer predisposition genes in triple-negative breast cancer patients
2024
·
M. Palleschi
, A. Virga
, et al.
·
ESMO Open
·
4
PDF
Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer
2023
·
Maria Concetta Cursano
, Emilio Francesco Giunta
, et al.
·
International Journal of Molecular Sciences
·
3
PDF
Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor–targeting therapy
2026
·
Sara Bleve
, Francesco Ravera
, et al.
·
Prostate Cancer and Prostatic Diseases
·
2
PDF
Mutational and low-coverage whole genome sequencing identifies actionable DNA repair alterations in prostate cancer plasma DNA
2025
·
Alessandra Virga
, Milena Urbini
, et al.
·
Scientific Reports
·
2
PDF
700P Detection of circulating tumor DNA and chromosome 3p25.3 gain in relapsed/refractory germ cell tumors and impact of salvage high-dose chemotherapy: Results from the Italian Germ Cell Cancer Group 04 study
2024
·
U. De Giorgi
, M. Polano
, et al.
·
Annals of Oncology
·
2
PDF
Abstract 7610: Predictive biomarkers for immuno-chemotherapy response in biliary tract malignancies
2024
·
Michele Zanoni
, Tania Rossi
, et al.
·
Cancer Research
·
1
Association of changing bone metastatic (mets) patterns with dynamics of circulating tumor DNA (ctDNA) in metastatic castration-resistant prostate cancer (mCRPC).
2022
·
Vincenza Conteduca
, Emanuela Scarpi
, et al.
·
Journal of Clinical Oncology
·
1
Plasma and Tissue Assessment of Homologous Recombination Deficiency-related Genomic Instability in Prostate Cancer
2026
·
Alessandra Virga
, Milena Urbini
, et al.
·
The Journal of Liquid Biopsy
PDF
Molecular Profiling of Bile-derived DNA: New Perspectives for the Diagnosis and Management of Biliopancreatic Tumors
2026
·
Giorgia Marisi
, Michele Zanoni
, et al.
·
The Journal of Liquid Biopsy
PDF
Elucidating PI3K / AKT / PTEN Pathway Alterations at Single‐Cell Level in CTCs From HR +/ HER2 − Metastatic Breast Cancer
2026
·
Tania Rossi
, Michela Palleschi
, et al.
·
Cancer Science
PDF
Reply to: Time-Varying Effects of Copy Number Alteration Clustering: Methodologic Concerns in Survival Analysis of Relapsed/Refractory Germ Cell Tumors
2026
·
Milena Urbini
, Thomas F. Eleveld
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
41
Citation count:
230
H-index:
9
I10-index:
8
Year
Topic
Type